Seeing Is Believing
Currently out of the existing stock ratings of Frank Takkinen, 112 are a BUY (94.92%), 6 are a HOLD (5.08%).
Analyst Frank Takkinen, currently employed at LAKE STREET, carries an average stock price target met ratio of 47.17% that have a potential upside of 38.19% achieved within 120 days.
Frank Takkinen’s has documented 232 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SGHT, Sight Sciences at 20-Oct-2025.
Analyst best performing recommendations are on COCH (ENVOY MEDICAL).
The best stock recommendation documented was for NOTV (INOTIV) at 5/16/2024. The price target of $2 was fulfilled within 1 day with a profit of $0.14 (6.54%) receiving and performance score of 65.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$90
$12.48 (16.10%)
$125
15 days ago
(14-Oct-2025)
16/34 (47.06%)
$11.16 (14.16%)
208
Hold
$89
$11.48 (14.81%)
$230
1 months 8 days ago
(21-Sep-2025)
4/8 (50%)
$10.47 (13.33%)
264
Buy
$150
$72.48 (93.50%)
$240
2 months 25 days ago
(04-Aug-2025)
12/14 (85.71%)
$62.09 (70.63%)
124
Hold
$140
$62.48 (80.60%)
$175
2 months 25 days ago
(04-Aug-2025)
10/13 (76.92%)
$52.09 (59.25%)
41
Buy
$150
$72.48 (93.50%)
$233
2 months 25 days ago
(04-Aug-2025)
20/24 (83.33%)
$62.09 (70.63%)
194
Which stock is Frank Takkinen is most bullish on?
Which stock is Frank Takkinen is most reserved on?
What Year was the first public recommendation made by Frank Takkinen?